125 related articles for article (PubMed ID: 24579680)
41. Effects of zoledronic acid on physiologic bone remodeling of condylar part of TMJ: a radiologic and histomorphometric examination in rabbits.
Tatli U; Ustün Y; Kürkçü M; Benlidayı ME
ScientificWorldJournal; 2014; 2014():649026. PubMed ID: 24688415
[TBL] [Abstract][Full Text] [Related]
42. Histopathological features of bisphosphonates related osteonecrosis of the jaw in rats with and without vitamin d supplementation.
Yanık S; Aras MH; Erkılıç S; Bozdağ Z; Demir T; Çetiner S
Arch Oral Biol; 2016 May; 65():59-65. PubMed ID: 26854621
[TBL] [Abstract][Full Text] [Related]
43. Changes in cortical bone channels network and osteocyte organization after the use of zoledronic acid.
Rabelo GD; Travençolo BA; Oliveira MA; Beletti ME; Gallottini M; Silveira FR
Arch Endocrinol Metab; 2015 Dec; 59(6):507-14. PubMed ID: 26331228
[TBL] [Abstract][Full Text] [Related]
44. Effects of systemic zoledronic Acid administration on osseointegration of hydroxyapatite-coated and resorbable blast material surface implants in rabbit models.
Yaman F; Ağaçayak S; Atilgan S; Benlidayi E; Ucan MC; Erol B; Kaya B; Gunay A; Guven S
Int J Oral Maxillofac Implants; 2012; 27(6):1443-7. PubMed ID: 23189295
[TBL] [Abstract][Full Text] [Related]
45. Exercise and zoledronic acid on lipid profile and bone remodeling in ovariectomized rats: a paradoxical negative association?
Lespessailles E; Jaffré C; Rochefort GY; Dolléans E; Benhamou CL; Courteix D
Lipids; 2010 Apr; 45(4):337-44. PubMed ID: 20229125
[TBL] [Abstract][Full Text] [Related]
46. Bisphosphonates suppress periosteal osteoblast activity independently of resorption in rat femur and tibia.
Iwata K; Li J; Follet H; Phipps RJ; Burr DB
Bone; 2006 Nov; 39(5):1053-1058. PubMed ID: 16807159
[TBL] [Abstract][Full Text] [Related]
47. Mevalonates restore zoledronic acid-induced osteoclastogenesis inhibition.
Nagaoka Y; Kajiya H; Ozeki S; Ikebe T; Okabe K
J Dent Res; 2015 Apr; 94(4):594-601. PubMed ID: 25535203
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesis.
Akbulut Y; Gul M; Dundar S; Ozcan EC; Ozercan IH; Bozoglan A; Karasu N; Acikan I; Bingül MB
J Craniofac Surg; 2021 Nov-Dec 01; 32(8):2901-2905. PubMed ID: 33935139
[TBL] [Abstract][Full Text] [Related]
49. Oncologic doses of zoledronic acid induce site specific suppression of bone modelling in rice rats.
Exposto CR; Oz U; Callard JS; Allen MJ; Khurana H; Atri A; Mo X; Fernandez SA; Tatakis DN; Edmonds K; Westgate PM; Huja SS
Orthod Craniofac Res; 2017 Jun; 20 Suppl 1():83-88. PubMed ID: 28643933
[TBL] [Abstract][Full Text] [Related]
50. Zoledronate reduces unwanted bone resorption in intercalary bone allografts.
Seo SW; Cho SK; Storer SK; Lee FY
Int Orthop; 2010 Apr; 34(4):599-603. PubMed ID: 19343345
[TBL] [Abstract][Full Text] [Related]
51. The effect of systemically administrated zoledronic acid on the osseointegration of dental implants.
Ayan M; Dolanmaz D; Mihmanlı A; Ayan A; Kürkçü M
Oral Dis; 2012 Nov; 18(8):802-8. PubMed ID: 22712806
[TBL] [Abstract][Full Text] [Related]
52. Histomorphometric evaluation of the effects of zoledronic acid on mandibular distraction osteogenesis in rabbits.
Pampu AA; Dolanmaz D; Tüz HH; Avunduk MC; Kişnişci RS
J Oral Maxillofac Surg; 2008 May; 66(5):905-10. PubMed ID: 18423279
[TBL] [Abstract][Full Text] [Related]
53. Comparison of Fc-osteoprotegerin and zoledronic acid activities suggests that zoledronic acid inhibits prostate cancer in bone by indirect mechanisms.
Quinn JE; Brown LG; Zhang J; Keller ET; Vessella RL; Corey E
Prostate Cancer Prostatic Dis; 2005; 8(3):253-9. PubMed ID: 15999121
[TBL] [Abstract][Full Text] [Related]
54. The effect of zoledronic acid and denosumab on the mandible and other bones: a
Fushimi M; Ohbayashi Y; Nakai F; Norikane T; Yamamoto Y; Nishiyama Y; Miyake M
Oral Radiol; 2022 Oct; 38(4):594-600. PubMed ID: 35142984
[TBL] [Abstract][Full Text] [Related]
55. Effect of Primary Stabilisation on Osseointegration of Implants With Local and Systemic Zoledronic Acid Application.
Sokmen N; Dundar S; Bozoglan A; Yildirim TT; Sokmen K; Sayeste E; Isayev A; Kirtay M
J Craniofac Surg; 2022 Jul-Aug 01; 33(5):1276-1281. PubMed ID: 34560734
[TBL] [Abstract][Full Text] [Related]
56. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
Hui SK; Fairchild GR; Kidder LS; Sharma M; Bhattacharya M; Jackson S; Le C; Yee D
Calcif Tissue Int; 2012 Jan; 90(1):40-9. PubMed ID: 22083107
[TBL] [Abstract][Full Text] [Related]
57. Zoledronic Acid Modulates Cytokine Expression and Mitigates Bone Loss during the Development of Induced Apical Periodontitis in a Mice Model.
Maia CA; Chaves HGDS; Benetti F; de Menezes GB; Antunes MM; Pinto KP; Silva EJNL; Sobrinho APR; Tavares WLF
J Endod; 2023 Nov; 49(11):1522-1528. PubMed ID: 37633518
[TBL] [Abstract][Full Text] [Related]
58. [Effects of local application of zoledronic acid on bone healing of tooth extraction in rats].
Ma T; Zhang WY; Zhang J; Wang M; Cui CW
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Jul; 46(7):403-5. PubMed ID: 22041628
[TBL] [Abstract][Full Text] [Related]
59. Transient retention of endochondral cartilaginous matrix with bisphosphonate treatment in a long-term rabbit model of distraction osteogenesis.
Smith EJ; McEvoy A; Little DG; Baldock PA; Eisman JA; Gardiner EM
J Bone Miner Res; 2004 Oct; 19(10):1698-705. PubMed ID: 15355565
[TBL] [Abstract][Full Text] [Related]
60. Effect of zoledronic acid on spinal fusion outcomes in an ovariectomized rat model of osteoporosis.
Yasen M; Li X; Jiang L; Yuan W; Che W; Dong J
J Orthop Res; 2015 Sep; 33(9):1297-304. PubMed ID: 26011820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
